TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 45 filers reported holding TERNS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $16,614,001 | -31.9% | 1,898,743 | -7.8% | 0.36% | -34.7% |
| Q1 2023 | $24,383,545 | -16.0% | 2,059,421 | -27.8% | 0.54% | -9.5% |
| Q4 2022 | $29,026,102 | +165.0% | 2,851,287 | +53.3% | 0.60% | +175.7% |
| Q3 2022 | $10,955,000 | +57.2% | 1,860,000 | -20.7% | 0.22% | +39.7% |
| Q1 2022 | $6,967,000 | -58.0% | 2,345,959 | 0.0% | 0.16% | -55.2% |
| Q4 2021 | $16,586,000 | -32.1% | 2,345,959 | 0.0% | 0.35% | -27.0% |
| Q3 2021 | $24,445,000 | -15.0% | 2,345,959 | 0.0% | 0.48% | -6.7% |
| Q2 2021 | $28,761,000 | -44.3% | 2,345,959 | 0.0% | 0.51% | -52.9% |
| Q1 2021 | $51,611,000 | – | 2,345,959 | – | 1.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |